Search
Search Constraints
You searched for: Author/Creator Verlant, VincentLimit your search
- Verlant, Vincent [remove] 7
- 615.372 5
- Vaccines -- Periodicals 5
- 614.4 1
- 616.9 1
- AE adverse event -- ATP according-to-protocol -- CI confidence interval -- dPly pneumolysin toxoid -- ELISA enzyme-linked immunosorbent assay -- EPI Expanded Program on Immunization -- GMC geometric mean concentration -- IPD invasive pneumococcal disease -- non-10VT non-PHiD-CV pneumococcal serotypes or serogroups -- NPC nasopharyngeal carriage -- PCV pneumococcal conjugate vaccine -- PHiD-CV pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine -- PhtD pneumococcal histidine triad protein D -- Ply pneumolysin -- qPCR quantitative polymerase chain reaction -- SAE serious adverse event 1
- ATP according-to-protocol -- CI confidence interval -- dPly pneumolysin toxoid -- DTPw-HBV/Hib diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b vaccine -- ELISA enzyme-linked immunosorbent assay -- EPI Expanded Programme on Immunisation -- GMC geometric mean concentration -- GMT geometric mean titre -- IPD invasive pneumococcal disease -- IU International Units -- OPA opsonophagocytic activity -- OPV oral trivalent polio vaccine -- PCV pneumococcal conjugate vaccine -- PCV13 13-valent pneumococcal conjugate vaccine -- PHiD-CV pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine -- PHiD-CV/dPly/PhtD pneumococcal vaccine that contains 10 PHiD-CV polysaccharide conjugates combined with conserved pneumococcal proteins - pneumolysin toxoid and pneumococcal histidine triad protein D -- PhtD pneumococcal histidine triad protein D -- PS polysaccharide -- PRP polyribosyl-ribitol-phosphate -- TCID50 50% tissue culture infectious dose -- TVC total vaccinated cohort -- WHO World Health Organization 1
- BSA bovine serum albumin -- CI confidence interval -- CWPS multi pneumococcal cell wall polysaccharide multi -- DPBS Dulbecco's phosphate buffered saline -- DPBST Dulbecco's phosphate buffered saline containing 0.05% Tween-20 -- ECL electrochemiluminescence -- ELISA enzyme-linked immunosorbent assay -- GMR geometric mean of the ratios -- ICH Institute of Child Health -- IgG immunoglobulin G -- IPD invasive pneumococcal disease -- LLOQ lower limit of quantitation -- MSD Meso Scale Discovery -- PCV pneumococcal conjugate vaccine -- PCV13 13-valent pneumococcal conjugate vaccine -- PCV7 7-valent pneumococcal conjugate vaccine -- PCV9 9-valent pneumococcal conjugate vaccine -- PHiD-CV pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine -- PnPS pneumococcal capsular polysaccharide -- RCDC reverse cumulative distribution curve -- ROC receiver operating characteristics -- ULOQ upper limit of quantitation -- WHO World Health Organization 1
- Communicable diseases -- Periodicals 1
- Detoxification -- mouse -- pneumococcal antigen -- pneumolysin -- Streptococcus pneumoniae -- vaccine 1
- Electrochemiluminescence assay -- Enzyme-linked immunosorbent assay -- Pneumococcal polysaccharides -- Threshold -- Bridging -- Concordance 1